INO Financial Facts
Total revenue: 12.54MLoss from operations: -20.2M
See Full Income Statement
Additional paid-in capital: 552.75M
Total liabilities: 47.57M
See Full Balance Sheet
Inovio Pharma (INO) Earnings
|
Expand Research on INO
| Next EPS Date | 5/8/24 | EPS Growth Rate | -625.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +55.3% | Revenue Growth Rate | +490.9% |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/01  |
Q117 | N/A | -$0.31 | N/A | N/A | $5.83M | = | N/A | N/A | ||
| 11/15/10 |
Q310 | -$0.01 | -$0.03 | +$0.02 | N/A | N/A | N/A |  | | Details | |
| 3/17/11 |
Q410 | -$0.06 | -$0.03 | -$0.03 | $2.4M | $1.3M | N/A | | | Details | |
| 5/11/11 |
Q111 | -$0.02 | -$0.04 | +$0.02 | $2.7M | $1.74M | N/A | | | Details | |
| 8/8/11 |
Q211 | -$0.02 | -$0.05 | +$0.03 | $2.4M | $1.79M | N/A | | | Details | |
| 11/7/11 | Q311 | -$0.04 | -$0.03 | -$0.01 | $2.64M | $1.87M | N/A | | | Details | |
| 3/15/12 | Q411 | -$0.04 | -$0.05 | +$0.01 | $1.6M | $2.1M | N/A | | | Details | |
| 5/9/12 | Q112 | -$0.06 | -$0.04 | -$0.02 | $1.7M | $2.1M | N/A | | | Details |
